HD-OPM Archive
Topics › Supplements & vitamins

Low omega-3 index (<4%) linked to mortality risk comparable to smoking in Framingham data

Louis Nervegna · Jul 21, 2025 · ♥ 11 reactions · 3 comments · original Facebook post
Supplements & vitaminsAging & longevity
AI summary & key facts

Louis shares a clip summarising observational Framingham Heart Study data on the omega-3 index and notes the research is mostly observational but compelling. The shared text claims a low omega-3 index carries mortality risk similar to smoking and that raising it to about 8% could add roughly five years of life expectancy.

The research she is describing is mostly observational, but it is compelling nonetheless.

Some of it comes from the famous Framingham Heart Study, arguably the highest-quality long-term prospective cohort study ever conducted in cardiology.

#omega3HD #omega3indexHD #fishoilHD #billharrisHD #rhondapatrickHD #framinghamHD

Research cited

Supplementing omega-3 might be one of the simplest ways to extend your lifespan

Research from the Framingham study shows a low omega-3 index (under 4%) carries a mortality risk comparable to smoking

On top of that, studies show that boosting your omega-3 index from low to optimal (~8%) can increase life expectancy by about five years

Yet, nearly 90% of Americans don't meet daily EPA & DHA requirements (~250 mg/day)—easily corrected by eating fish or supplementing with fish oil


Catch the full interview here:

▶Video · YouTube · Dr. Mayim BialikTop Supplements to Prevent Cancer, Feel Better & Stop Inflammation | Dr. Rhonda PatrickWhat if aging didn’t have to mean decline? On Mayim Bialik's Breakdown, Dr. Rhonda Patrick (Ph.D. in biomedical science, expert in nutritional biochemistry and aging, and founder of FoundMyFitness) reveals to Mayim & Jonathan the cutting-edge science behind living longer, feeling sharper, and preventing disease with evidence-based lifestyle changes. In this…youtube.com
← newer: Vitamin D acts as a neurosteroid: receptors in the brain andolder: Erythritol and brain blood-vessel cells: clarifying a TV war →